31 May 2017

On the way to recovery

The Vidi programme targets excellent researchers with several years of experience after their PhD. These researchers belong to the best of their respective disciplines. The Vidi programme enables them to do research for five years, which is how NWO hopes to stimulate innovation in science.

Vidi grant for Vivian Weerdesteyn - Theme Disorders of movement
Following a stroke, humans often struggle with balance and walking. This impacts their  safety and autonomy tremendously, which is a problem especially in our aging society. It is still unknown how different neural pathways contribute to the recovery of balance and walking after a stroke. Dr. Weerdesteyn and her colleagues are going to change this. They will furthermore attempt to facilitate recovery through training in order to improve functioning in daily life.

> see the personal page of Vivian Weerdesteyn for more information about her research

 

More information


Researcher profile

Related news items


Rob Aarnoutse is appointed as professor in Translation pharmacology of antimicrobial agents in particular drugs for tuberculosis

25 January 2021

Hospital pharmacist and clinical pharmacologist Rob Aarnoutse is appointed as professor in ‘Translation pharmacology of antimicrobial agents, in particular drugs for tuberculosis’ at Radboud University / Radboudumc, starting 16 November 2020.

read more

Oral health research makes significant impact at the 148th WHO Executive Board meeting

25 January 2021

During the 148th session of the World Health Organization (WHO) Executive Board meeting, Member States passed a game-changing resolution on oral health. WHO Director General Dr Tedros Adhanom Ghebreyesus called it a “landmark resolution”.

read more

Radboud Young Academy safeguards the future of science

21 January 2021

New platform to provide advice on policy, create an interdisciplinary network of early career scientists, and promote career development.

read more

Increase radio- and immunotherapy efficacy by targeting hypoxia

21 January 2021

In a paper recently accepted by Clinical Cancer Research, Daan Boreel, together with Paul Span, Sandra Heskamp, Gosse Adema and Jan Bussink, reviews the therapeutic potential of decreasing the lack of oxygen (hypoxia) often found in solid tumors.

read more

Radiation boost lowers risk of prostate cancer recurrence

21 January 2021

An additional external-beam radiation dose delivered directly to the tumor can benefit the prospects of men with non-metastatic prostate cancer, without causing additional side effects. The risk of relapse within five years for these men is smaller than for men who did not receive this boost.

read more

New research through grants for Radboudumc researchers

14 January 2021

Several researchers at the Radboudumc have received grants to start new studies, including on rare diseases, liver disease and cancer metastases. These are grants from the Dutch Research Council, European Joint Programme on Rare Diseases and the Gastric Liver Disease Foundation.

read more